Title:
HYBRID GRAFT FOR THERAPY OF AORTIC PATHOLOGY AND ASSOCIATED METHOD
Document Type and Number:
WIPO Patent Application WO/2013/163140
Kind Code:
A3
Abstract:
Vascular devices and methods for addressing aortic pathologies are provided that facilitate hemostasis at the junctions of the ends of the device with the native aorta or other vessels to minimize or eliminate the risk of endoleaks. One or both ends of the device may include inner and outer skirts that are configured to receive a section of native blood vessel there between. The outer skirt may be flared in some cases or rolled up prior to placement at and engagement with the blood vessel to provide clearance for joining the blood vessel to the inner skirt of the device, such as via sutures. Once engaged, the outer skirt is disposed such that the blood vessel is between the inner and outer skirts. Devices and associated methods are also described that allow endografts to be deployed and engaged with an end of the device in areas with insufficient landing zones.
More Like This:
Inventors:
MADJAROV JEKO METODIEV (US)
MADZHAROV SVETOZAR (BG)
MADZHAROV SVETOZAR (BG)
Application Number:
PCT/US2013/037734
Publication Date:
March 27, 2014
Filing Date:
April 23, 2013
Export Citation:
Assignee:
CHARLOTTE MECKLENBURG HOSPITAL (US)
International Classes:
A61F2/06
Domestic Patent References:
| WO2009046994A2 | 2009-04-16 | |||
| WO1997003616A1 | 1997-02-06 | |||
| WO2011084559A2 | 2011-07-14 |
Foreign References:
| US4957508A | 1990-09-18 |
Attorney, Agent or Firm:
GLESSNER, Michele, M. et al. (Bank Of America Plaza101 South Tryon Street, Suite 400, Charlotte NC, US)
Download PDF: